Monoclonal anti-keratin (AE1) reactivity in routinely processed tissue from 166 human neoplasms.
A large number of human neoplasms were tested for their keratin expression in routinely processed tissues by a simple, three-stage immunoperoxidase method using a broadly reactive monoclonal anti-keratin antibody AE1, which recognizes a number of keratin polypeptides distributed in a wide variety of epithelia. All carcinomas, with the exception of hepatocellular, adrenocortical, and basal cell carcinomas and occasional renal cell, pulmonary small-cell, and pulmonary large-cell anaplastic carcinomas, reacted with this antibody irrespective of differentiation, in most instances displaying staining of strong or moderate intensity in the majority of tumor cells. Equivocal results were obtained in some seminomas and dysgerminomas. Malignant melanoma, large-cell lymphoma, Hodgkin's disease, malignant histiocytosis, and stromal mesenchymal elements in all tumors did not show any reactivity with AE1. Even after routine processing, the determinant detected by AE1 is conserved and restricted to epithelial neoplasms. This suggests that AE1 would be valuable in the diagnostic distinction of anaplastic carcinoma from lymphoma and melanoma in routinely processed tissues.
Spagnolo
D V
DV
Michie
S A
SA
Crabtree
G S
GS
Warnke
R A
RA
Rouse
R V
RV
D000911:Antibodies, Monoclonal / Q000276:immunology; D000918:Antibody Specificity; D002277:Carcinoma / Q000032:analysis; D004848:Epithelium / Q000032:analysis; D007124:Immunoenzyme Techniques; D007633:Keratins / Q000032:analysis* / Q000276:immunology; D009363:Neoplasm Proteins / Q000032:analysis* / Q000276:immunology; D009369:Neoplasms / Q000032:analysis* / Q000473:pathology
D000911:Antibodies, Monoclonal; D009363:Neoplasm Proteins; D007633:Keratins